Anesthetic Isoflurane Posttreatment Attenuates Experimental Lung Injury by Inhibiting Inflammation and Apoptosis

Figure 2

Treatment with 1.4% ISO attenuates lung damage in ZY-challenged mice. (a) Body weight change, (b) survival rate, (c) HE examination of lung (400x magnification), (d) lung histologic scores, (e) lung W/D ratio, (f) BALF total cell counts, (g) BALF neutrophil count, (h) BALF lymphocyte count, (i) BALF macrophage count, and (j) caspase-3 activity. The animals were treated as described in Figure 1. Data are mean ± SD (𝑛=10 mice per group). *𝑃<0.05 versus sham; ^#𝑃<0.05 versus ZY + vehicle.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)